tetano
Editor, Senior Moderator
PLoS One
. 2023 Mar 30;18(3):e0279897.
doi: 10.1371/journal.pone.0279897. eCollection 2023.
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction
Kei Yamamoto[SUP] 1 [/SUP], Yusuke Ohsiro[SUP] 2 [/SUP], Tetsuya Suzuki[SUP] 1 [/SUP], Michiyo Suzuki[SUP] 1 [/SUP], Sayaka Miura[SUP] 1 [/SUP], Maki Nagashima[SUP] 1 [/SUP], Noriko Iwamoto[SUP] 1 [/SUP], Junko S Takeuchi[SUP] 3 [/SUP], Moto Kimura[SUP] 3 [/SUP], Wataru Sugiura[SUP] 3 [/SUP], Satoru Nebuya[SUP] 4 [/SUP], Masato Kurokawa[SUP] 4 [/SUP], Norio Ohmagari[SUP] 1 [/SUP]
Affiliations
Abstract
Although biomarkers to predict coronavirus disease 2019 (COVID-19) severity have been studied since the early pandemic, no clear guidelines on using them in clinical practice are available. Here, we examined the ability of four biomarkers to predict disease severity using conserved sera from COVID-19 patients who received inpatient care between January 1, 2020 and September 21, 2021 at the National Center for Global Health and Medicine, collected at the appropriate time for prediction. We predicted illness severity in two situations: 1) prediction of future oxygen administration for patients without oxygen support within 8 days of onset (Study 1) and 2) prediction of future mechanical ventilation support (excluding non-invasive positive pressure ventilation) or death of patients within 4 days of the start of oxygen administration (Study 2). Interleukin-6, IFN-λ3, thymus and activation-regulated chemokine, and calprotectin were measured retrospectively. Other laboratory and clinical information were collected from medical records. AUCs were calculated from ROC curves and compared for the predictive ability of the four biomarkers. Study 1 included 18 patients, five of whom had developed oxygen needs. Study 2 included 45 patients, 13 of whom required ventilator management or died. In Study 1, IFN-λ3 showed a good predictive ability with an AUC of 0.92 (95% CI 0.76-1.00). In Study 2, the AUC of each biomarker was 0.70-0.74. The number of biomarkers above the cutoff showed the possibility of good prediction with an AUC of 0.86 (95% CI 0.75-0.97). When two or more biomarkers were positive, sensitivity and specificity were 0.92 and 0.63, respectively. In terms of biomarker testing at times when prognostication may be clinically useful, IFN-λ3 was predictive of oxygenation demand and a combination of the four biomarkers was predictive of mechanical ventilator requirement.
. 2023 Mar 30;18(3):e0279897.
doi: 10.1371/journal.pone.0279897. eCollection 2023.
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction
Kei Yamamoto[SUP] 1 [/SUP], Yusuke Ohsiro[SUP] 2 [/SUP], Tetsuya Suzuki[SUP] 1 [/SUP], Michiyo Suzuki[SUP] 1 [/SUP], Sayaka Miura[SUP] 1 [/SUP], Maki Nagashima[SUP] 1 [/SUP], Noriko Iwamoto[SUP] 1 [/SUP], Junko S Takeuchi[SUP] 3 [/SUP], Moto Kimura[SUP] 3 [/SUP], Wataru Sugiura[SUP] 3 [/SUP], Satoru Nebuya[SUP] 4 [/SUP], Masato Kurokawa[SUP] 4 [/SUP], Norio Ohmagari[SUP] 1 [/SUP]
Affiliations
- PMID: 36996138
- DOI: 10.1371/journal.pone.0279897
Abstract
Although biomarkers to predict coronavirus disease 2019 (COVID-19) severity have been studied since the early pandemic, no clear guidelines on using them in clinical practice are available. Here, we examined the ability of four biomarkers to predict disease severity using conserved sera from COVID-19 patients who received inpatient care between January 1, 2020 and September 21, 2021 at the National Center for Global Health and Medicine, collected at the appropriate time for prediction. We predicted illness severity in two situations: 1) prediction of future oxygen administration for patients without oxygen support within 8 days of onset (Study 1) and 2) prediction of future mechanical ventilation support (excluding non-invasive positive pressure ventilation) or death of patients within 4 days of the start of oxygen administration (Study 2). Interleukin-6, IFN-λ3, thymus and activation-regulated chemokine, and calprotectin were measured retrospectively. Other laboratory and clinical information were collected from medical records. AUCs were calculated from ROC curves and compared for the predictive ability of the four biomarkers. Study 1 included 18 patients, five of whom had developed oxygen needs. Study 2 included 45 patients, 13 of whom required ventilator management or died. In Study 1, IFN-λ3 showed a good predictive ability with an AUC of 0.92 (95% CI 0.76-1.00). In Study 2, the AUC of each biomarker was 0.70-0.74. The number of biomarkers above the cutoff showed the possibility of good prediction with an AUC of 0.86 (95% CI 0.75-0.97). When two or more biomarkers were positive, sensitivity and specificity were 0.92 and 0.63, respectively. In terms of biomarker testing at times when prognostication may be clinically useful, IFN-λ3 was predictive of oxygenation demand and a combination of the four biomarkers was predictive of mechanical ventilator requirement.